Form 4: Axogen Director Receives Equity Grant

Axogen, Inc. Director John Johnson was granted 4,392 restricted stock units as an annual equity award for his service.

Summary

• John Johnson, a Director at Axogen, Inc., received an annual equity grant on June 24, 2026.
• The grant consists of 4,392 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Axogen, Inc. common stock.
• The value of the equity grant was $185,000 as of the grant date.
• These RSUs are scheduled to vest on June 24, 2027, which is one year after the grant date.
• This award is for Mr. Johnson's service as a Director on the Axogen, Inc. Board of Directors.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine equity grant for director compensation and does not contain new financial performance data or strategic shifts.

Positives

• Director compensation in the form of equity aligns management interests with shareholders.
• The grant of 4,392 RSUs valued at $185,000 indicates continued investment in key leadership.
• The one-year vesting period encourages retention and long-term commitment.

Future Outlook

The restricted stock units granted to Director John Johnson are set to vest on June 24, 2027, indicating a forward-looking incentive for continued service.

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard practice in the biotechnology and medical device sectors, such as Axogen, Inc., to attract and retain experienced leadership and align their financial interests with long-term company performance and shareholder value.

Stakeholder Impact

• Shareholders: The equity grant reinforces director commitment, potentially aligning their interests with long-term shareholder value creation. The value of the grant is a component of overall compensation expenses.
• Employees: This filing does not directly impact employees, but it reflects the company's compensation strategy for its board.
• Management: The grant is part of the compensation structure for the board of directors.

Next Steps

• Director John Johnson will hold the restricted stock units until their vesting date on June 24, 2027.
• Upon vesting, the RSUs will convert into shares of Axogen, Inc. common stock.

Key Dates

Keywords

Axogen Inc, AXGN, Form 4, SEC Filing, Director Compensation, Equity Grant, Restricted Stock Units, John Johnson, Insider Trading, Beneficial Ownership